Melanie L Graham is a Professor of Surgery at the Medical School and a Professor of Veterinary Population Medicine at the College of Veterinary Medicine, the University of Minnesota. She received her MPH in Epidemiology at the University of Minnesota and her PhD at Utrecht University. She has received numerous awards, including the Andreas von Recum Award (2022), the C. William Hall Outstanding Publication Award (2019), the Endowed Robert and Katherine Goodale Chair in Minimally Invasive Surgery (2019), and The Patrick J. Manning Award (2004). Her research is inspired by her training in surgery, epidemiology, and primatology, working with key leaders in obesity, immunology, surgery, and transplantation for more than 20 years. The research emphasis of her laboratory and center is the development of cell-, gene-, and immuno-therapies targeting metabolic, autoimmune, infectious, and inherited diseases using highly refined modeling. Parallel to this work, she has developed innovative behavioral management strategies that interface behaviors and sociality to accurately reflect the intended patient population to enhance model validity and improve animal welfare to accelerate clinical translation.
Melanie L Graham is a Professor of Surgery at the Medical School and a Professor of Veterinary Population Medicine at the College of Veterinary Medicine, the University of Minnesota. She received her MPH in Epidemiology at the University of Minnesota and her PhD at Utrecht University. She has received numerous awards, including the Andreas von Recum Award (2022), the C. William Hall Outstanding Publication Award (2019), the Endowed Robert and Katherine Goodale Chair in Minimally Invasive Surgery (2019), and The Patrick J. Manning Award (2004). Her research is inspired by her training in surgery, epidemiology, and primatology, working with key leaders in obesity, immunology, surgery, and transplantation for more than 20 years. The research emphasis of her laboratory and center is the development of cell-, gene-, and immuno-therapies targeting metabolic, autoimmune, infectious, and inherited diseases using highly refined modeling. Parallel to this work, she has developed innovative behavioral management strategies that interface behaviors and sociality to accurately reflect the intended patient population to enhance model validity and improve animal welfare to accelerate clinical translation.